Grufity logoGrufity logo

Carlyle Group Inc (The) Stock Research

CG

35.43USD+0.13(+0.37%)Market Closed

Market Summary

USD35.43+0.13
Market Closed
0.37%

CG Stock Price

CG RSI Chart

CG Valuation

Market Cap

12.9B

Price/Earnings (Trailing)

7.5

Price/Sales (Trailing)

2.25

EV/EBITDA

5.41

Price/Free Cashflow

67.51

CG Price/Sales (Trailing)

CG Profitability

EBT Margin

40.40%

Return on Equity

25.79%

Return on Assets

8.14%

Free Cashflow Yield

1.48%

CG Fundamentals

CG Revenue

Revenue (TTM)

5.7B

Revenue Y/Y

-33.61%

Revenue Q/Q

3.77%

CG Earnings

Earnings (TTM)

1.7B

Earnings Y/Y

-48.41%

Earnings Q/Q

13.46%

Price Action

52 Week Range

24.3252.27
(Low)(High)

Last 7 days

4.6%

Last 30 days

22.1%

Last 90 days

24.5%

Trailing 12 Months

-21.9%

CG Financial Health

Debt/Equity

0.34

Debt/Cashflow

0.1

CG Investor Care

Dividend Yield

3.78%

Shares Dilution (1Y)

2.08%

Diluted EPS (TTM)

4.79

Peers (Alternatives to Carlyle Group The)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
68.0B
12.6B
32.84% -15.74%
26.26
5.4
-38.48% -50.30%
44.6B
7.2B
10.72% -30.31%
-106.97
6.15
-48.93% -107.37%
33.8B
-
13.10% 15.34%
10.39
2.44
6.62% 23.70%
15.3B
8.3B
18.79% 1.50%
11.88
1.85
-1.78% -29.45%
MID-CAP
8.3B
-
2.35% -11.79%
9.02
1.05
2.53% -21.61%
6.4B
2.5B
7.50% 21.24%
11.73
2.58
9.09% 8.59%
6.2B
1.2B
10.61% -4.48%
26.59
5.27
-39.99% -44.40%
5.0B
3.1B
17.30% 12.82%
7.91
1.63
-1.79% -4.92%
4.3B
2.4B
11.36% -23.48%
13.4
1.79
-12.52% -53.48%
3.8B
3.1B
17.84% 2.83%
7.26
1.22
-0.74% 3.54%
SMALL-CAP
2.0B
597.8M
16.04% 14.93%
21.72
3.27
20.12% 2505.47%
570.3M
162.6M
6.10% 11.13%
13.09
3.51
-6.65% -38.27%
506.5M
40.4M
6.98% 3.46%
27.82
12.54
1.01% -33.76%
233.1M
554.5M
12.43% -49.38%
92.91
0.42
-42.93% -98.83%
161.6M
197.7M
0.84% -7.62%
4
0.82
5.01% -33.91%

Financials for Carlyle Group The

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue-8.8%5,7186,2697,9278,7828,298
  S&GA Expenses10.6%519469446432409
Costs and Expenses-6.6%3,3503,5894,3144,7574,510
EBITDA-11.0%2,5432,8583,782--
EBITDA Margin-2.4%0.44*0.46*0.48*--
Earnings Before Taxes-12.9%2,3102,6533,6064,0283,815
EBT Margin-4.5%0.40*0.42*0.45*--
Interest Expenses-0.5%11912011811398
Net Income-13.4%1,7161,9812,6792,9752,939
Net Income Margin-5.0%0.30*0.32*0.34*--
Free Cahsflow-68.0%1915961,306--
* denotes actual numbers (not divided by Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-1.6%21,09221,42521,73621,25020,789
    Cash Equivalents4.0%1,3621,3091,2902,4702,399
  Net PPE-2.9%134138145144139
  Goodwill711.0%103131313-
Liabilities-3.7%14,43814,99315,38215,54415,756
  Long Term Debt-0.2%2,2352,2392,2552,0722,371
    LT Debt, Non Current-0.2%2,2352,2392,2552,0722,371
Shareholder's Equity3.5%6,6556,4326,3545,7065,033
  Retained Earnings3.7%3,4313,3103,2072,8052,324
  Additional Paid-In Capital2.9%3,1233,0342,9822,7182,672
Shares Outstanding0.6%363361362355356
Minority Interest20.4%537446444427274
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-63.9%2306371,3501,7911,244
  Share Based Compensation7.0%180169170163149
Cashflow From Investing-33.7%-877.60-656.30-653.20-32.20-41.70
Cashflow From Financing-31.8%-311.50-236.30-255.80-242.50276
  Dividend Payments7.5%415386357356355
  Buy Backs-7.4%22424223216285

Risks for CG

What is the probability of a big loss on CG?

71.2%


Probability that Carlyle Group The stock will be more than 20% underwater in next one year

50%


Probability that Carlyle Group The stock will be more than 30% underwater in next one year.

30.4%


Probability that Carlyle Group The stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CG drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Carlyle Group The was unfortunately bought at previous high price.

Drawdowns

Returns for CG

Cumulative Returns on CG

7.9%


10-Year Cumulative Returns

21.0%


7-Year Cumulative Returns

11.3%


5-Year Cumulative Returns

5.4%


3-Year Cumulative Returns

What are the long-term rolling returns for CG?

FIve years rolling returns for Carlyle Group The.

Annualized Returns

Which funds bought or sold CG recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-01-26
STRS OHIO
unchanged
-
172,000
1,283,000
0.01%
2023-01-26
Riverview Trust Co
sold off
-100
-10,000
-
-%
2023-01-26
Sumitomo Mitsui DS Asset Management Company, Ltd
unchanged
-
42,602
318,602
0.01%
2023-01-26
Yorktown Management & Research Co Inc
unchanged
-
42,304
316,304
0.39%
2023-01-25
FIFTH THIRD BANCORP
unchanged
-
9,200
65,200
-%
2023-01-25
Steel Peak Wealth Management LLC
sold off
-100
-438,000
-
-%
2023-01-25
STEPHENS INC /AR/
reduced
-1.45
267,000
2,202,000
0.04%
2023-01-24
XPONANCE, INC.
new
-
217,713
217,713
-%
2023-01-24
NATIONAL BANK OF CANADA /FI/
added
84.44
33,046,200
62,292,200
0.16%
2023-01-24
Sigma Planning Corp
added
0.55
206,402
1,485,400
0.05%

1–10 of 49

Latest Funds Activity

Are funds buying CG calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CG
No. of Funds

Carlyle Group The News

Best Stocks

The Carlyle Group Inc. is purchased by Raymond James & ....

Best Stocks,
12 days ago

Holland & Knight

Tysons Reporter

Nasdaq

Mergers & Acquisitions

The Business Journals

Seeking Alpha

Schedule 13G FIlings of Carlyle Group The

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jun 14, 2022
carlyle group management l.l.c.
42.1%
152,131,004
SC 13D/A
Feb 14, 2022
vulcan value partners, llc
4.66%
16,609,123
SC 13G/A
Feb 11, 2022
conway william e jr
9.0%
31,999,644
SC 13G/A
Feb 11, 2022
capital world investors
5.4%
19,315,259
SC 13G
Feb 11, 2022
d'aniello daniel a.
9.3%
32,999,644
SC 13G/A
Feb 11, 2022
rubenstein david m.
8.8%
31,249,644
SC 13G/A
Feb 10, 2022
morgan stanley
5.1%
18,224,322
SC 13G
Feb 09, 2022
vanguard group inc
5.31%
18,920,948
SC 13G
Nov 19, 2021
carlyle group management l.l.c.
43.7%
155,855,386
SC 13D/A
Aug 31, 2021
carlyle group management l.l.c.
45.4%
162,010,246
SC 13D/A

CG Fair Value

Recent SEC filings of Carlyle Group The

View All Filings
Date Filed Form Type Document
Jan 23, 2023
SC 13D
13D - Major Acquisition
Jan 23, 2023
3
Insider Trading
Jan 20, 2023
S-8
Employee Benefits Plan
Jan 03, 2023
4
Insider Trading
Dec 20, 2022
SC 13D/A
13D - Major Acquisition
Dec 01, 2022
40-6B/A
40-6B/A
Nov 10, 2022
13F-HR
Fund Holdings Report
Nov 08, 2022
8-K
Current Report
Nov 08, 2022
10-Q
Quarterly Report

Latest Insider Trading transactions for CG

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-08-01
Finn Christopher
sold
-1,288,940
37.85
-34,054
chief operating officer
2022-08-01
Larson Bruce M.
sold
-330,923
37.85
-8,743
chief human resources officer
2022-08-01
Ferguson Jeffrey W.
sold
-343,300
37.85
-9,070
general counsel
2022-08-01
Buser Curtis L.
sold
-1,471,990
37.85
-38,890
chief financial officer
2022-08-01
Andrews Charles Elliott Jr.
sold
-177,819
37.85
-4,698
chief accounting officer
2022-07-15
CLARE PETER J
acquired
-
-
14,404
see remarks.
2022-06-09
CLARE PETER J
acquired
-
-
13,262
see remarks.
2022-06-06
Rubenstein David M.
sold
-77,340,000
38.67
-2,000,000
-
2022-05-01
ORDAN MARK S
acquired
-
-
5,236
-
2022-05-01
HANCE JAMES H JR
acquired
-
-
5,236
-

1–10 of 50

Kewsong Lee
1850
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations a

CG Income Statement

2022-09-30
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues    
Investment income$ 422,300,000$ 1,134,900,000$ 1,846,700,000$ 5,318,500,000
Interest and other income35,500,00021,900,00092,500,00063,300,000
Interest and other income of Consolidated Funds79,700,00062,100,000204,600,000185,300,000
Total revenues1,088,500,0001,639,500,0003,719,300,0006,783,000,000
Compensation and benefits    
Cash-based compensation and benefits251,400,000224,900,000779,700,000685,200,000
Equity-based compensation54,200,00042,400,000139,300,000122,000,000.0
Performance allocations and incentive fee related compensation163,500,000495,200,000741,200,0002,355,800,000
Total compensation and benefits469,100,000762,500,0001,660,200,0003,163,000,000
General, administrative and other expenses149,200,00099,600,000387,200,000300,400,000
Interest27,300,00027,900,00082,000,000.076,400,000
Interest and other expenses of Consolidated Funds53,700,00044,600,000137,100,000133,500,000
Other non-operating expenses300,0003,500,000800,0001,000,000.0
Total expenses699,600,000938,100,0002,267,300,0003,674,300,000
Other income    
Net investment income (loss) of Consolidated Funds(30,300,000)(100,000)(51,000,000.0)9,600,000
Income before provision for income taxes358,600,000701,300,0001,401,000,0003,118,300,000
Provision for income taxes76,200,000153,900,000274,900,000733,500,000
Net income282,400,000547,400,0001,126,100,0002,384,800,000
Net income attributable to non-controlling interests in consolidated entities1,600,00014,600,00028,300,00057,700,000
Net income attributable to common shares$ 280,800,000$ 532,800,000$ 1,097,800,000$ 2,327,100,000
Net income attributable to The Carlyle Group Inc. per common share (see Note 14)    
Basic (in dollars per share)$ 0.77$ 1.50$ 3.04$ 6.56
Diluted (in dollars per share)$ 0.77$ 1.46$ 3.00$ 6.42
Weighted-average common shares    
Basic (in shares)362,895,064355,954,734360,657,999354,903,371
Diluted (in shares)366,787,149364,740,675365,389,217362,471,998
Fund management fees    
Revenues    
Fund management fees and incentive fees$ 535,900,000$ 407,500,000$ 1,532,900,000$ 1,182,900,000
Incentive fees    
Revenues    
Fund management fees and incentive fees15,100,00013,100,00042,600,00033,000,000.0
Performance allocations    
Revenues    
Investment income298,100,000974,500,0001,346,200,0004,841,300,000
Principal investment income    
Revenues    
Investment income$ 124,200,000$ 160,400,000$ 500,500,000$ 477,200,000

CG Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Assets  
Cash and cash equivalents$ 1,361.9$ 2,469.5
Cash and cash equivalents held at Consolidated Funds177.2147.8
Restricted cash0.65.6
Corporate treasury investments69.50.0
Investments, including accrued performance allocations of $7,428.7 million and $8,133.0 million as of September 30, 2022 and December 31, 2021, respectively10,998.210,832.0
Investments of Consolidated Funds6,409.76,661.0
Due from affiliates and other receivables, net486.4379.6
Due from affiliates and other receivables of Consolidated Funds, net108.6138.8
Fixed assets, net134.4143.9
Lease right-of-use assets, net333.5361.1
Deposits and other69.461.7
Intangible assets, net925.134.9
Deferred tax assets17.914.5
Total assets21,092.421,250.4
Liabilities and equity  
Debt obligations2,235.02,071.6
Loans payable of Consolidated Funds5,516.95,890.0
Accounts payable, accrued expenses and other liabilities379.4379.7
Accrued compensation and benefits4,347.74,955.0
Due to affiliates351.6388.1
Deferred revenue394.2120.8
Deferred tax liabilities449.9487.1
Other liabilities of Consolidated Funds222.0683.9
Lease liabilities499.9537.8
Accrued giveback obligations40.930.2
Total liabilities14,437.515,544.2
Commitments and contingencies
Common stock, $0.01 par value, 100,000,000,000 shares authorized (363,372,564 and 355,367,876 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively)3.63.6
Additional paid-in-capital3,123.02,717.6
Retained earnings3,430.82,805.3
Accumulated other comprehensive loss(439.7)(247.5)
Non-controlling interests in consolidated entities537.2427.2
Total equity6,654.95,706.2
Total liabilities and equity$ 21,092.4$ 21,250.4